Literature DB >> 15093967

High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan.

Yu Nakamura1, Motoasa Koh, Eiji Miyoshi, Osamu Ida, Masayuki Morikawa, Akihiro Tokuyama, Tatsuji Nagano, Yoshiharu Honda, Junzo Iida, Kunya Yamamoto, Naoki Minami, Akinori Kasahara, Motoharu Hirai, Norio Hayashi, Toshifumi Kishimoto.   

Abstract

Prevalence of anti-HCV antibody in 1193 hospitalized patients (848 males and 345 females) in psychiatric department was investigated. Overall prevalence ratio was 9.1%, indicating significantly higher than that of healthy blood donors. In the classification of ICD-10, the prevalence of the inpatients diagnosed in schizophrenia group and psychoactive substance use group accounted for 6.2% and 13.8%, respectively. However, adequate reasons such as sanitary issues were not found to account for the high prevalence. Only the age of the patients could account for the high prevalence in the schizophrenic group. In the psychoactive substance abuse group, the sanitary issues might be a major cause of the very high prevalence of anti-HCV antibody, while other factors such as dysfunction of the immune system might be considered to account for it.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093967     DOI: 10.1016/j.pnpbp.2004.01.018

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

3.  Prevalence and Predictors of Toxoplasma gondii Infection in Psychiatric Inpatients in Fars Province, Southern Iran.

Authors:  Aref Teimouri; Othman Jamal Nassrullah; Pouya Hedayati; Mohammad Saleh Bahreini; Rasoul Alimi; Sina Mohtasebi; Amir Masoud Salemi; Qasem Asgari
Journal:  Front Psychiatry       Date:  2022-06-14       Impact factor: 5.435

4.  Hepatitis B and C among veterans on a psychiatric ward.

Authors:  James H Tabibian; Donna A Wirshing; Joseph M Pierre; Lisa H Guzik; Michael D Kisicki; Itai Danovitch; Shirley J Mena; William C Wirshing
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 5.  Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis.

Authors:  Elizabeth Hughes; Shaan Bassi; Simon Gilbody; Martin Bland; Fabiola Martin
Journal:  Lancet Psychiatry       Date:  2015-11-29       Impact factor: 27.083

6.  Seroepidemiological Study of Toxoplasma gondii Infection among Psychiatric Patients in Mashhad, Northeast of Iran.

Authors:  Ebrahim Abdollahian; Reza Shafiei; Naghmeh Mokhber; Kurosh Kalantar; Abdolmajid Fata
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

7.  Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study.

Authors:  Jur-Shan Cheng; Jing-Hong Hu; Ming-Yu Chang; Ming-Shyan Lin; Hsin-Ping Ku; Rong-Nan Chien; Ming-Ling Chang
Journal:  J Psychiatry Neurosci       Date:  2021-11-02       Impact factor: 6.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.